hsa-mir-5787: Hsa-mir-5787 is a microRNA (miRNA) that has been identified in various studies as having significant expression levels in different biological contexts. It has been found to be highly expressed in comparisons between T-M and H:T-M, as well as between BM-M and H:BM-M [PMC8139033]. Furthermore, hsa-mir-5787 has been implicated in interactions with AD-related neurofibrillary pathology and BCAS4/SHISA7 [PMC8899724]. It has also been identified as a target of lnc-FAM72D and lnc-EPC1-4, with implications for hepatocellular carcinoma (HCC) [PMC7343450]. In addition, hsa-mir-5787 has been found to be differentially expressed in apigenin-treated cells compared to control cells [PMC8095173]. The miRNA hsa-mir-5787 is consistently identified as one of the top miRNAs in various analyses, along with other miRNAs such as hsa-miR-4763-3p, hsa-miR-149-3p, hsa-miR-762, and hsa-miR-6791-5p [PMC5002491]. It has also been implicated in the regulation of circ-RANBP9 and LAMA2 for precision treatment [PMC8039645]. Hsa-mir-5787 is predicted to interact with several other miRNAs such as hsa-miR-4739, hsa-miR6195p, and hsa-miR78513p [PMC8806466]. Furthermore, it has been shown to inhibit cell growth by targeting eukaryotic translation initiation factor 5 (EIF5) [PMC9028476], regulate inflammation mediated by macrophages through TLR4/NF-kappaB signaling [PMC9436632], and be involved in ceRNA regulation networks [PMC6151003]. Overall, hsa-mir-5787 is a miRNA that has been consistently identified in various studies and has implications in different biological processes and diseases.